| FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular … C Cremolini, F Loupakis, C Antoniotti, C Lupi, E Sensi, S Lonardi, S Mezi, ... The Lancet Oncology 16 (13), 1306-1315, 2015 | 1119 | 2015 |
| Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials R Iacovelli, A Palazzo, S Mezi, F Morano, G Naso, E Cortesi Acta Oncologica 51 (7), 873-879, 2012 | 91 | 2012 |
| Incidence and relative risk of hepatic toxicity in patients treated with anti‐angiogenic tyrosine kinase inhibitors for malignancy R Iacovelli, A Palazzo, G Procopio, M Santoni, P Trenta, A De Benedetto, ... British journal of clinical pharmacology 77 (6), 929-938, 2014 | 71 | 2014 |
| Follow-up program in head and neck cancer F De Felice, M de Vincentiis, V Valentini, D Musio, S Mezi, LL Mele, ... Critical Reviews in Oncology/Hematology 113, 151-155, 2017 | 58 | 2017 |
| Anti–PD-1 and anti–PD-L1 in head and neck cancer: a network meta-analysis A Botticelli, A Cirillo, L Strigari, F Valentini, B Cerbelli, S Scagnoli, ... Frontiers in immunology 12, 705096, 2021 | 57 | 2021 |
| Standard of care and promising new agents for triple negative metastatic breast cancer P Mancini, A Angeloni, E Risi, E Orsi, S Mezi Cancers 6 (4), 2187-2223, 2014 | 51 | 2014 |
| Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells S Mezi, L Todi, E Orsi, A Angeloni, P Mancini International journal of oncology 41 (6), 2128-2138, 2012 | 51 | 2012 |
| The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy A Botticelli, A Cirillo, S Scagnoli, B Cerbelli, L Strigari, A Cortellini, ... Vaccines 8 (2), 203, 2020 | 50 | 2020 |
| Advances in the management of HPV-related oropharyngeal cancer F De Felice, V Tombolini, V Valentini, M De Vincentiis, S Mezi, ... Journal of oncology 2019, 2019 | 50 | 2019 |
| Tobacco, alcohol and family history of cancer as risk factors of Oral Squamous Cell Carcinoma: Case-control retrospective study G Tenore, A Nuvoli, A Mohsen, A Cassoni, A Battisti, V Terenzi, ... Applied Sciences 10 (11), 3896, 2020 | 45 | 2020 |
| Management of salivary gland malignant tumor: the Policlinico Umberto I,“Sapienza” University of Rome Head and Neck Unit clinical recommendations F De Felice, M de Vincentiis, V Valentini, D Musio, S Mezi, LL Mele, ... Critical Reviews in Oncology/Hematology 120, 93-97, 2017 | 35 | 2017 |
| Neuroendocrine tumors of the gallbladder: a case report and review of the literature S Mezi, V Petrozza, O Schillaci, V La Torre, B Cimadon, M Leopizzi, E Orsi, ... Journal of Medical Case Reports 5, 1-5, 2011 | 35 | 2011 |
| The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study A Botticelli, IG Zizzari, S Scagnoli, G Pomati, L Strigari, A Cirillo, B Cerbelli, ... Journal of Personalized Medicine 11 (7), 651, 2021 | 30 | 2021 |
| Tryptophan catabolism as immune mechanism of primary resistance to anti-PD-1 A Botticelli, S Mezi, G Pomati, B Cerbelli, E Cerbelli, M Roberto, R Giusti, ... Frontiers in Immunology 11, 519631, 2020 | 30 | 2020 |
| The role of opioids in cancer response to immunotherapy A Botticelli, A Cirillo, G Pomati, B Cerbelli, S Scagnoli, M Roberto, ... Journal of Translational Medicine 19, 1-10, 2021 | 27 | 2021 |
| 99mTc MIBI prone scintimammography in patients with suspicious breast cancer: relationship with mammography and tumor size. F Scopinaro, S Mezi, M Ierardi, G De Vincentis, NS Tiberio, V David, ... International journal of oncology 12 (3), 661-665, 1998 | 26 | 1998 |
| 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography. F Scopinaro, M Ierardi, LM Porfiri, NS Tiberio, G De Vincentis, S Mezi, ... Anticancer research 17 (3B), 1635-1638, 1997 | 26 | 1997 |
| In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography S Mezi, F Primi, F Capoccetti, F Scopinaro, M Modesti, O Schillaci International journal of oncology 22 (6), 1233-1240, 2003 | 23 | 2003 |
| Clinical significance of epithelial‐to‐mesenchymal transition in laryngeal carcinoma: Its role in the different subsites S Mezi, C Chiappetta, R Carletti, A Nardini, E Cortesi, E Orsi, G Piesco, ... Head & Neck 39 (9), 1806-1818, 2017 | 21 | 2017 |
| Management of metastatic renal cell carcinoma progressed after sunitinib or another antiangiogenic treatment R Iacovelli, A Palazzo, P Trenta, S Mezi, D Pellegrino, G Naso, E Cortesi American journal of clinical oncology 37 (6), 611-615, 2014 | 19 | 2014 |
Orazio SchillaciEmail verificata su uniroma2.it
Orazio SchillaciEmail verificata su uniroma2.it